IA
RMD icon

Icon Advisers’s ResMed RMD Stock Holding History

Icon Advisers’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-22,500
Closed -$1.06M – 345
2013
Q4 		$1.06M Buy
22,500
+15,000
+200% +$759K 0.08% 177
2013
Q3 		$396K Sell
7,500
-47,600
-86% -$2.31M 0.03% 261
2013
Q2 		$2.49M Buy
+55,100
New +$2.61M 0.19% 123

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Icon Advisers's RMD Position: Q1 2014 in Review

Icon Advisers sold out of ResMed (RMD) in Q1 2014, closing a stake of 22,500 shares — an estimated $1.06M sold.

Icon Advisers first reported a position in RMD in Q2 2013 and held it in 3 quarters. The position peaked at $2.49M in Q2 2013. 318 funds tracked by Wall St. Rank hold RMD as of Q1 2014.

  • Icon Advisers reported no remaining ResMed position as of Q1 2014 after selling out during the quarter.
  • Icon Advisers sold 22,500 ResMed shares in Q1 2014, an estimated $1.06M.
  • Icon Advisers first reported a position in ResMed in Q2 2013 and held it in 3 quarters.
  • Icon Advisers's ResMed position peaked at $2.49M in Q2 2013.
  • 318 funds tracked by Wall St. Rank held ResMed as of Q1 2014.

Based on Icon Advisers's 13F filing for Q1 2014, filed 7 May 2014.